17
answers
2
watching
311
views
rafi_mokdadLv1
1 Feb 2023
When it comes to using clinical data collected outside of the US to support a US regulatory submission, it’s important to understand that:
a. FDA expects clinical trial design and conduct to conform with relevant local regulations and applicable Good Clinical Practices
b. FDA looks critically at data obtained from foreign studies in terms of its applicability to the US patient population
c. FDA reserves the right to audit foreign clinical sites to confirm whether or not the data is valid for the purposes of obtaining an approval to market a device in the U.S
d. All of the above
When it comes to using clinical data collected outside of the US to support a US regulatory submission, it’s important to understand that:
a. FDA expects clinical trial design and conduct to conform with relevant local regulations and applicable Good Clinical Practices
b. FDA looks critically at data obtained from foreign studies in terms of its applicability to the US patient population
c. FDA reserves the right to audit foreign clinical sites to confirm whether or not the data is valid for the purposes of obtaining an approval to market a device in the U.S
d. All of the above
Liked by mehdotstorm and 1 others
hirdayrana789Lv10
17 Dec 2023
Already have an account? Log in
teacherrecoLv10
9 Aug 2023
Already have an account? Log in
marcusnicole284Lv10
15 Jun 2023
Already have an account? Log in
akunuru639Lv10
3 Jun 2023
Already have an account? Log in
viclere2005Lv10
14 May 2023
Already have an account? Log in
Read by 1 person
Read by 1 person
Read by 1 person
Read by 1 person
larryrambo777Lv10
14 Feb 2023
Already have an account? Log in
Read by 1 person
9 Feb 2023
Already have an account? Log in
Read by 2 people
pinkyvaishu2Lv2
2 Feb 2023
Already have an account? Log in
Read by 1 person